JP2022531251A5 - - Google Patents

Info

Publication number
JP2022531251A5
JP2022531251A5 JP2021564572A JP2021564572A JP2022531251A5 JP 2022531251 A5 JP2022531251 A5 JP 2022531251A5 JP 2021564572 A JP2021564572 A JP 2021564572A JP 2021564572 A JP2021564572 A JP 2021564572A JP 2022531251 A5 JP2022531251 A5 JP 2022531251A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
administration
salt
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021564572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022531251A (ja
JP7545414B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/053938 external-priority patent/WO2020222108A1/en
Publication of JP2022531251A publication Critical patent/JP2022531251A/ja
Publication of JP2022531251A5 publication Critical patent/JP2022531251A5/ja
Application granted granted Critical
Publication of JP7545414B2 publication Critical patent/JP7545414B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021564572A 2019-04-30 2020-04-27 ヒト免疫不全ウイルス複製阻害剤 Active JP7545414B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962840434P 2019-04-30 2019-04-30
US62/840,434 2019-04-30
PCT/IB2020/053938 WO2020222108A1 (en) 2019-04-30 2020-04-27 Inhibitors of human immunodeficiency virus replication

Publications (3)

Publication Number Publication Date
JP2022531251A JP2022531251A (ja) 2022-07-06
JP2022531251A5 true JP2022531251A5 (cg-RX-API-DMAC7.html) 2023-04-26
JP7545414B2 JP7545414B2 (ja) 2024-09-04

Family

ID=70482731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021564572A Active JP7545414B2 (ja) 2019-04-30 2020-04-27 ヒト免疫不全ウイルス複製阻害剤

Country Status (4)

Country Link
US (1) US20220211704A1 (cg-RX-API-DMAC7.html)
EP (1) EP3962603A1 (cg-RX-API-DMAC7.html)
JP (1) JP7545414B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020222108A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA53973A (fr) 2018-10-24 2022-02-09 Viiv Healthcare Uk No 5 Ltd Inhibiteurs de la réplication du virus de l'immunodéficience humaine
IL293566A (en) * 2019-12-09 2022-08-01 Viiv Healthcare Co Pharmaceutical preparations containing Cabotgravir
TW202448483A (zh) 2023-05-31 2024-12-16 美商基利科學股份有限公司 用於hiv之治療性化合物
AR132951A1 (es) 2023-06-15 2025-08-13 Viiv Healthcare Uk No 5 Ltd Métodos e intermedios para preparar compuestos
WO2025169059A1 (en) 2024-02-05 2025-08-14 VIIV Healthcare UK (No.5) Limited Inhibitors of human immunodeficiency virus replication

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102464654B (zh) 2010-11-12 2016-01-13 上海泓博智源医药技术有限公司 抗病毒化合物
CA2840095A1 (en) 2011-07-06 2013-01-10 Gilead Sciences, Inc. Compounds for the treatment of hiv
CN102863512B (zh) 2011-07-07 2016-04-20 上海泓博智源医药技术有限公司 抗病毒化合物
US9220710B2 (en) 2013-01-09 2015-12-29 Gilead Sciences, Inc. Therapeutic compounds
TW201443037A (zh) 2013-01-09 2014-11-16 Gilead Sciences Inc 治療用化合物
EP2943493B1 (en) 2013-01-09 2017-08-02 Gilead Sciences, Inc. Therapeutic compounds for the treatment of viral infections
TWI694071B (zh) 2013-03-01 2020-05-21 美商基利科學股份有限公司 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
WO2015130964A1 (en) 2014-02-28 2015-09-03 Gilead Sciences, Inc. Therapeutic compounds
WO2015130966A1 (en) 2014-02-28 2015-09-03 Gilead Sciences, Inc. Antiviral agents
US9873680B2 (en) 2014-08-29 2018-01-23 Gilead Sciences, Inc. Therapeutic compounds
LT3347352T (lt) 2016-08-19 2019-08-12 Gilead Sciences, Inc. Terapiniai junginiai, naudotini živ viruso infekcijos profilaktikai arba terapiniam gydymui
TW201906834A (zh) 2017-05-02 2019-02-16 英商Viiv醫療保健英國(No.5)有限公司 人類免疫不全病毒複製之抑制劑
PT3870575T (pt) * 2018-10-25 2023-05-12 Viiv Healthcare Uk No 5 Ltd Inibidores da replicação do vírus da imunodeficiência humana
JP2022506399A (ja) * 2018-11-05 2022-01-17 ヴィーブ ヘルスケア ユーケー(ナンバー5)リミテッド ヒト免疫不全ウイルス複製の阻害剤

Similar Documents

Publication Publication Date Title
JP2022537047A5 (cg-RX-API-DMAC7.html)
JP6628828B2 (ja) Hivを治療するためのトール様受容体の調節因子
HRP20240501T1 (hr) Derivati pirido[2,3-d]pirimidina kao inhibitori replikacije virusa humane imunodeficijencije
JP2022191257A5 (cg-RX-API-DMAC7.html)
JP2022523726A5 (cg-RX-API-DMAC7.html)
JP2024540183A5 (cg-RX-API-DMAC7.html)
JP2009535352A5 (cg-RX-API-DMAC7.html)
RU2002111657A (ru) ГЕКСАГИДРОФУРО [2,3-b] ФУРАН-3-ИЛ-N-{3-[(1,3-БЕНЗОДИОКСОЛ-5-ИЛСУЛЬФОНИЛ) (ИЗОБУТИЛ) АМИНО]-1-БЕНЗИЛ-2-ГИДРОКСИПРОПИЛ} КАРБАМАТ КАК ИНГИБИТОР РЕТРОВИРУСНОЙ ПРОТЕАЗЫ
JP2022525013A5 (cg-RX-API-DMAC7.html)
JP2022551691A5 (cg-RX-API-DMAC7.html)
JP2020512337A5 (cg-RX-API-DMAC7.html)
JP2015522630A5 (cg-RX-API-DMAC7.html)
JP2017533972A5 (cg-RX-API-DMAC7.html)
JP2022505597A5 (cg-RX-API-DMAC7.html)
JP2002528502A5 (cg-RX-API-DMAC7.html)
JP2016516773A5 (cg-RX-API-DMAC7.html)
JP2019533660A5 (cg-RX-API-DMAC7.html)
JP2023537921A5 (cg-RX-API-DMAC7.html)
JP2025508656A5 (cg-RX-API-DMAC7.html)
RU2019135261A (ru) Фармацевтическая композиция, содержащая ингибитор pde9
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
JP2023531930A5 (cg-RX-API-DMAC7.html)
JP2023553253A5 (cg-RX-API-DMAC7.html)
JP2025520237A5 (ja) 哺乳動物の非結核性マイコバクテリア感染症治療薬
JP2023502053A5 (cg-RX-API-DMAC7.html)